AMENDMENT NO. 2 TO CREDIT AGREEMENTCredit Agreement • October 14th, 2021 • Candela Medical, Inc. • Electromedical & electrotherapeutic apparatus • New York
This AMENDMENT AGREEMENT (this “Amendment No. 2”), dated as of July 19, 2018, made by and among Syneron Medical Ltd, a company formed under the laws of the State of Israel (the “Israeli Borrower”), Syneron, Inc., a Delaware corporation (the “U.S. Borrower” and, together with the Israeli Borrower, the “Borrower”), Lupert Ltd, a company formed under the laws of the State of Israel (“Israeli Holdings”), ING Capital LLC (“ING”), as Administrative Agent (the “Administrative Agent”), and each lender party hereto amends the Credit Agreement, dated as of September 20, 2017, (as amended by that certain Amendment No. 1, dated as of October 8, 2017, and as further amended, restated, supplemented, amended and restated or otherwise modified from time to time, the “ Existing Credit Agreement”) among Holdings, the Borrower, ING as Administrative Agent and Collateral Agent and each Lender from time to time party thereto. Capitalized terms used but not defined herein shall have the meanings assigned to
WAIVER AND AMENDMENT NO. 3 TO CREDIT AGREEMENTCredit Agreement • October 14th, 2021 • Candela Medical, Inc. • Electromedical & electrotherapeutic apparatus • New York
This WAIVER AND AMENDMENT NO. 3 (this “Amendment No. 3”), dated as of September 24, 2019, made by and among Syneron Medical Ltd, a company formed under the laws of the State of Israel (the “Israeli Borrower”), Syneron, Inc., a Delaware corporation (the “U.S. Borrower” and, together with the Israeli Borrower, the “Borrower”), Lupert Ltd, a company formed under the laws of the State of Israel (“Lupert”) and Candela Holdings, LLC, a Delaware limited liability company (“Holdings”), ING Capital LLC (“ING”), as Administrative Agent (the “Administrative Agent”), and each lender party hereto, amends the Credit Agreement, dated as of September 20, 2017, (as amended by that certain Amendment No. 1, dated as of October 8, 2017, and that certain Amendment No. 2, dated as of July 18, 2018, and as further amended, restated, supplemented, amended and restated or otherwise modified from time to time, the “Existing Credit Agreement”) among Holdings, the Borrower, Lupert, ING as Administrative Agent and
AMENDMENT NO. 1 TO CREDIT AGREEMENTCredit Agreement • October 14th, 2021 • Candela Medical, Inc. • Electromedical & electrotherapeutic apparatus • New York
This AMENDMENT AGREEMENT (this “Amendment No. 1”), dated as of October 8, 2017, made by and among Syneron Medical Ltd, a company formed under the laws of the State of Israel (the “Israeli Borrower”), Syneron, Inc., a Delaware corporation (the “U.S. Borrower” and, together with the Israeli Borrower, the “Borrower”), Lupert Ltd, a company formed under the laws of the State of Israel (“Israeli Holdings”), ING Capital LLC (“ING”), as Administrative Agent (the “Administrative Agent”), and each lender party hereto amends the Credit Agreement, dated as of September 20, 2017, (as amended, restated, supplemented, amended and restated or otherwise modified from time to time, the “Existing Credit Agreement”) among Holdings, the Borrower, ING as Administrative Agent and Collateral Agent and each Lender from time to time party thereto. Capitalized terms used but not defined herein shall have the meanings assigned to such terms in the Existing Credit Agreement.
CREDIT AGREEMENT Dated as of September 20, 2017 Among Lupert Ltd, as Holdings, Syneron Medical Ltd and Syneron, Inc. as the Borrowers, ING Capital LLC, as Administrative Agent and Collateral Agent, THE OTHER LENDERS FROM TIME TO TIME PARTY HERETO ING...Security Agreement • October 14th, 2021 • Candela Medical, Inc. • Electromedical & electrotherapeutic apparatus • New York
This CREDIT AGREEMENT is entered into as of September 20, 2017, among Syneron Medical Ltd, a company formed under the laws of the State of Israel (the “Israeli Borrower”). Syneron, Inc., a Delaware corporation (the “U.S. Borrower” and, together with the Israeli Borrower, the “Borrower”), Lupert Ltd, a private company formed under the laws of the State of Israel (“Israeli Holdings”), ING Capital LLC (“ING”), as Administrative Agent and Collateral Agent, and each lender from time to time party hereto (collectively, the “Lenders” and, individually, a “Lender”; each as hereafter further defined).
